I agree that this site is using cookies. You can find further informations here.
X
VIPRAKASIT, V.
75  results:
Search for persons X
?
1

P1562: CHARACTERIZING IRON OVERLOAD BY AGE IN PATIENTS DIAG..:

Bianchi, P. ; Grace, R. F. ; Vives Corrons, J.-L....
HemaSphere.  6 (2022)  - p. 1443-1444 , 2022
Link: https://doi.org/10.1097/..
 
?
2

P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN T..:

Grace, R. F. ; Glenthøj, A. ; Barcellini, W....
HemaSphere.  6 (2022)  - p. 1426-1427 , 2022
Link: https://doi.org/10.1097/..
 
?
3

P1518: LONG-TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUS..:

Viprakasit, V. ; Cappellini, M. D. ; Porter, J. B....
HemaSphere.  6 (2022)  - p. 1399-1400 , 2022
Link: https://doi.org/10.1097/..
 
?
4

S270: LONGER-TERM ANALYSIS OF EFFICACY OF LUSPATERCEPT VERS..:

Cappellini, M. D. ; Taher, A. T. ; Porter, J. B....
HemaSphere.  6 (2022)  - p. 171-172 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOU..:

Kuo, K ; Layton, D ; Al-Samkari, H...
HemaSphere.  6 (2022)  - p. 23-24 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P1544: BONE MINERAL DENSITY REMAINS STABLE IN PYRUVATE KINA..:

Al-Samkari, H. ; Grace, R. F. ; Glenthøj, A....
HemaSphere.  6 (2022)  - p. 1425-1426 , 2022
Link: https://doi.org/10.1097/..
 
?
7

ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BL..:

Kuo, KH ; Layton, DM ; Al-Samkari, H...
Hematology, Transfusion and Cell Therapy.  43 (2021)  - p. S20 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Evaluation of potassium peroxymonosulfate (MPS) efficacy ag..:

Tulalamba, W. ; Assawamakin, A. ; Thayananuphat, A..
International Journal of Infectious Diseases.  110 (2021)  - p. 162-164 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Prevalence of hematologic conditions in samples received fo..:

Pratumvinit, B. ; Reesukumal, K. ; Kamkang, P....
Clinica Chimica Acta.  493 (2019)  - p. S303-S304 , 2019
Link: https://doi.org/10.1016/..
 
?
10

α−thalassaemia: a genotype–phenotype correlation and manage..:

Viprakasit, V.
ISBT Science Series.  10 (2015)  S1 - p. 295-304 , 2015
Link: https://doi.org/10.1111/..
 
?
11

When to consider transfusion therapy for patients with non‐..:

Taher, A. T. ; Radwan, A. ; Viprakasit, V.
Vox Sanguinis.  108 (2014)  1 - p. 1-10 , 2014
Link: https://doi.org/10.1111/..
 
?
12

What is the evidence of a role for host genetics in suscept..:

HORBY, P. ; SUDOYO, H. ; VIPRAKASIT, V....
Epidemiology and Infection.  138 (2010)  11 - p. 1550-1558 , 2010
Link: https://www.jstor.org/st..
 
?
13

Common origin of a rare beta-globin initiation codon mutati..:

VIPRAKASIT, V. ; CHINCHANG, W. ; SUWANTHOL, L..
Clinical and Laboratory Haematology.  27 (2005)  6 - p. 409-415 , 2005
Link: https://doi.org/10.1111/..
 
?
14

Papers to be published in forthcoming issues:

Viprakasit, V. ; Green, S. ; Height, S...
British Journal of Haematology.  117 (2002)  2 - p. 1-1 , 2002
Link: https://doi.org/10.1046/..
 
?
15

Mutations in the general transcription factor TFIIH result ..:

Viprakasit, V.
Human Molecular Genetics.  10 (2001)  24 - p. 2797-2802 , 2001
Link: https://doi.org/10.1093/..
 
1-15